داروسازی فارابی
دفارا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 19,980 2.99
Close Price: 19,930
Income Statement
AGM
Interim
2026/07/21 Fiscal Year 2026/03/2012 Month | 2025/05/27 Fiscal Year 2025/03/2012 Month | 2024/05/27 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 40.597 Trillion | 28.407 Trillion | 25.089 Trillion | |
Total Revenues | 40.597 Trillion | 28.407 Trillion | 25.089 Trillion | |
Cost of Goods Sold | 25.698 Trillion | 21.064 Trillion | 16.218 Trillion | |
Gross Profit | 14.899 Trillion | 7.343 Trillion | 8.871 Trillion | |
General & Administrative Expenses | 1.425 Trillion | 1.616 Trillion | 975.811 Billion | |
Net Operating Income & Expenses | 98.244 Billion | -53.978 Billion | 44.953 Billion | |
Operating Profit (Loss) | 13.573 Trillion | 5.673 Trillion | 7.94 Trillion | |
Profit Before Tax | 17.379 Trillion | 9.848 Trillion | 9.522 Trillion | |
Tax | 1.455 Trillion | 678.389 Billion | 1.545 Trillion | |
Net Profit (Loss) After Tax | 15.924 Trillion | 9.169 Trillion | 7.977 Trillion | |
Retained Earnings at Beginning of Period | 12.294 Trillion | 8.724 Trillion | 7.49 Trillion | |
Approved Dividends — Prior Year AGM | -8.6 Trillion | -5.6 Trillion | -6.742 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -3.1 Trillion | - | - | |
Allocable Profit | 16.517 Trillion | 12.294 Trillion | 8.724 Trillion | |
Legal Reserve | 760.6 Billion | - | - | |
Approved Dividends — Current Year | 8.562 Trillion | 8.6 Trillion | 5.6 Trillion | |
Retained Earnings at End of Period | 7.195 Trillion | 3.694 Trillion | 3.124 Trillion |